H. Lundbeck A/S HLBBF
Set alert
7.10 USD 0.00 0.00%
At close · Oct 30
7.10 Day range 7.10
5.70 52-week range 7.29
- YTD
- +3.50%
- 1 year
- -2.74%
- Open
- 7.10
- Prev close
- 7.10
- Mkt cap
- 7.04B
- Vol
- 100
- Avg vol
- 57
- EPS
- 0.61
- P/E
- 11.64
More statistics
- Low
- 7.10
- High
- 7.10
- Earnings
- Aug 19, 2026
6M chart
Events in this range
- May 12, 2026Earnings: 0.2575; estimate 0.2164; surprise 18.99%
- Aug 19, 2026Earnings: —; estimate 0.1718; surprise —%
Signals (20)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 15, 2026 | 2 weeks ago |
| RSI: Overbought | Oct 15, 2026 | 2 weeks ago |
| SMA: Bearish | Sep 14, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 14, 2026 | 1 month ago |
| SMA: Bullish | Aug 27, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 17, 2026 | 2 months ago |
| SMA: Bullish | Aug 14, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 10, 2026 | 2 months ago |
| SMA: Bearish | Aug 5, 2026 | 2 months ago |
| SMA: Bearish | Aug 5, 2026 | 2 months ago |
| SMA: Bullish | Jul 30, 2026 | 3 months ago |
| SMA: Bullish | Jul 30, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 30, 2026 | 3 months ago |
| SMA: Bearish | Jul 27, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 27, 2026 | 3 months ago |
| RSI: Oversold | Jul 27, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 14, 2026 | 3 months ago |
| SMA: Bearish | Jun 17, 2026 | 4 months ago |
| MACD: Sell Signal | May 18, 2026 | 5 months ago |
| RSI: Overbought | May 5, 2026 | 6 months ago |
Next earnings
Aug 19, 2026
Expected Aug 19, 2026. Consensus EPS estimate 0.1718.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 19, 2026 | Jun 30, 2026 | 0.1718 | — | — | — |
| May 12, 2026 | Mar 31, 2026 | 0.2164 | 0.2575 | +0.04 | +18.99% |
| Feb 3, 2026 | Dec 31, 2025 | 0.1136 | 0.00785 | -0.11 | -93.09% |
| Nov 11, 2025 | Sep 30, 2025 | 0.137 | 0.1743 | +0.04 | +27.23% |
| Aug 12, 2025 | Jun 30, 2025 | 0.1503 | 0.153 | 0.00 | +1.80% |
| May 14, 2025 | Mar 31, 2025 | 0.1297 | 0.1709 | +0.04 | +31.77% |
News
- H. Lundbeck A/S (HLBBF) Q2 2026 Earnings Call Transcript
- H. Lundbeck A/S (HLBBF) Discusses PROCEED Trial Results and Data Presented at AHS on Bokunebart for Headache Treatment Transcript
- H. Lundbeck A/S (HLBBF) Shareholder/Analyst Call Transcript
- H. Lundbeck A/S (HLBBF) Q4 2025 Earnings Call Transcript
- H. Lundbeck Launches Bid for Avadel in Move to Scuttle Alkermes Deal
- H. Lundbeck A/S (HLBBF) Q3 2025 Earnings Call Transcript
- Lundbeck's potential treatment for Multiple System Atrophy granted Orphan Drug Designation in Japan
Your note
Sign in to keep a note on HLBBF — it syncs with the Stock Master app.